DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Bertotti A. et al.
A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Cancer Discov 2011;
1: 508-523
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.